---
title: Accelerating Allogeneic Cell Therapies Through Clinically Compliant iPSC Line Generation
description: Download the Scientific poster presented by Suzanne Snellenberg at ISSCR 2026.
---

[Expert Insights ](https://www.cellistic.com/insights)

# [Accelerating Allogeneic Cell Therapies Through Clinically Compliant iPSC Line Generation](https://www.cellistic.com/insights/accelerating-allogeneic-cell-therapies-through-clinically-compliant-ipsc-line-generation)

 Written by [cellistic](https://www.cellistic.com/insights/author/cellistic) | Jul 14, 2026 10:34:55 AM

Generating clinically compliant iPSC lines is one of the biggest bottlenecks in allogeneic cell therapy — research-grade lines that later need re-derivation under GMP cause rework, delays, and added cost.

In a poster presented at the ISSCR’s Annual Meeting in Montréal, Canada, Suzanne Snellenberg shows how [Cellistic’s Pulse™ platform](https://www.cellistic.com/pulse-development-platform) builds ATMP-compliant Allo Chassis™ iPSC lines from the outset: donor-derived starting material, non-integrative reprogramming, and STAR-CRISPR™ gene editing to knock out B2M and CIITA, yielding HLA class I/II–null, immune-evasive lines with fully validated clonality and off-target safety.

The result is a GMP-aligned starting point that removes a major rework cycle between R&D and CDMO handoff.

[View full post](https://www.cellistic.com/insights/accelerating-allogeneic-cell-therapies-through-clinically-compliant-ipsc-line-generation)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "cellistic"
  },
  "dateModified" : "2026-07-17T14:55:06.760Z",
  "datePublished" : "2026-07-14T10:34:55Z",
  "headline" : "Accelerating Allogeneic Cell Therapies Through Clinically Compliant iPSC Line Generation",
  "image" : {
    "@type" : "ImageObject",
    "height" : 675,
    "url" : "https://www.cellistic.com/hubfs/Preview_Poster%20CLD%20%282%29.png",
    "width" : 1200
  },
  "mainEntityOfPage" : "https://www.cellistic.com/insights/accelerating-allogeneic-cell-therapies-through-clinically-compliant-ipsc-line-generation",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60.0,
      "url" : "https://21588612.fs1.hubspotusercontent-na1.net/hubfs/21588612/Cellistic_June2022/images/header-logo.png",
      "width" : 245.10638
    },
    "name" : "Expert Insights from Cellistic"
  }
}
```